New U.S. tax law kills multi-billion dollar pharmaceutical merger
Pfizer and Allergan scuttled its $160B merger after a new U.S. Treasury rule to curb companies from moving overseas for tax purposes; meanwhile, GAP gets into hot water for a possibly racially insensitive ad; Your Wednesday afternoon MoneyWatch headlines.